Stay updated on Biomarker-Directed Combo for Advanced Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the Biomarker-Directed Combo for Advanced Lung Cancer Clinical Trial page.

Latest updates to the Biomarker-Directed Combo for Advanced Lung Cancer Clinical Trial page
- Check7 days agoChange DetectedExpanded the study's active locations by adding numerous site locations across the United States, Canada, the United Kingdom, Europe, Australia, and Asia, and updated the revision to v3.3.3. This defines the new locations available for enrollment.SummaryDifference3%

- Check15 days agoNo Change Detected
- Check22 days agoNo Change Detected
- Check36 days agoChange DetectedA minor wording update to the publication note (changing 'the results of the study' to 'the study results') and a version revision to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check43 days agoChange DetectedAdded a new study site entry: Tainan, Taiwan, 704, and removed the old label Tainan City, Taiwan, 704. The funding-status notice about government funding was also removed.SummaryDifference0.2%

- Check57 days agoChange DetectedNo significant changes detected beyond metadata updates such as the last update date. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check86 days agoChange DetectedUpdated version to v3.2.0 and added a government-operating-status notice; removed the prior v3.1.0 tag.SummaryDifference2%

- Check93 days agoChange DetectedVersion bump from v3.0.2 to v3.1.0; no other content changes detected.SummaryDifference0.0%

Stay in the know with updates to Biomarker-Directed Combo for Advanced Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Biomarker-Directed Combo for Advanced Lung Cancer Clinical Trial page.